Features & Benefits
- Used for weight loss and weight maintenance in adults with overweight or obesity and related health issues
- Can be used in adolescents with weight problems
- Administered as a once-daily subcutaneous injection with a multidose pen
- Contains liraglutide, also found in Victoza, but with different strengths and FDA approvals
- Not approved for treating type 1 or type 2 diabetes
- Safety and effectiveness not established for children under 12 or for 12-17 year olds with type 2 diabetes
